申请人:Arvanitis Argyrios G.
公开号:US20090197869A1
公开(公告)日:2009-08-06
The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
本发明提供了调节Janus激酶活性的化合物,可用于治疗与Janus激酶活性相关的疾病,例如免疫相关疾病、皮肤疾病、髓系增生性疾病、癌症和其他疾病。